Skip to main content
. 2022 Aug 2;30(9):1778–1786. doi: 10.1002/oby.23505

TABLE 1.

Summary information on characteristics of studies contributing to main analysis

n/median (%/IQR)
N total trials 169
Sample size, median (IQR) 126 (65‐251)
Age (y), median (IQR) 49 (45‐56)
% Female, median (IQR) 73 (51‐100)
Mean BMI (kg/m2), median (IQR) 34 (31‐36)
Number of arms contributing to analysis, n studies (%)
2 136 (80)
3 27 (16)
4 4 (2)
6 1 (1)
7 1 (1)
Geographical region, n (%)
North America 94 (56)
South America 2 (1)
Europe 52 (31)
Asia 7 (4)
Australia and New Zealand 0 (0)
Africa 12 (7)
Mixed (Australia and Europe) 1 (1)
Missing 1 (1)
Selection based on disease status, n (%)
No 98 (58)
Yes 70 (41)
Missing 1 (1)
Recruitment method, n (%)
Self‐initiated 67 (40)
Prompted 72 (43)
Missing 30 (18)
Random sequence generation (selection bias), n (%)
Low 101 (60)
Unclear 67 (40)
High 1 (1)
Allocation concealment (selection bias), n (%)
Low 63 (37)
Unclear 106 (63)
High 0 (0)
Blinding of outcome (detection bias), n (%)
Low 147 (87)
Unclear 14 (8)
High 8 (5)
Incomplete outcome data (attrition bias), n (%) 169 (100)
Low 141 (83)
Unclear 7 (4)
High 21 (12)
Other bias, n (%)
Low 2 (1)
Unclear 13 (8)
High 17 (10)